Inhibition of proliferation of psoriatic and healthy fibroblasts in cell culture by selected dead-sea salts

Pharmacology

Volumn 52, Issue 5, 1996, Pages 321-328

  Levi Schaffer, Francesca ^a   Shani, Jashovam ^a   Politi, Yael ^b   Rubinchik, Evelina ^a   Brenner, Sara ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Cyclic AMP; Dead sea; Fibroblast proliferation; Magnesium; Potassium; Psoriasis

Indexed keywords

BROMIDE; CYCLIC AMP; MAGNESIUM CHLORIDE; MAGNESIUM SALT; MINERAL; POTASSIUM BROMIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL CULTURE; CELL DIVISION; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EMBRYO; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; SKIN BIOPSY; SKIN FIBROBLAST;

EID: 0030003988     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000139397     Document Type: Article

References (14)

1. Shani J, Barak S, Levi D, Ram M, Schachner ER, Schlesinger T, Rob-berecht R, Van Grieken R, Avrach WW; Skin penetration of minerals in psoriatics and guinea-pigs bathing in hypertonic salt solution, Pharmacol ResCommun 1985; 17:501-512.
2. Shani J, Evcn-Paz Z, Avrach WW, Rubinstein N, Livshin R, Justcsen NPB, Harkmark W: Topical replacement therapy of psoriasis by Dead-sea salts, evaluated by scanning electron microscopy and X-ray fluorescence, Dermatosen Beruf Umwelt 1991;39:49-55.
3. Shani J, Tur E, Wald E, Landau M, Shteiman S, Brenner S, Sela J: Computerized morphometry of psoriatic keratinocytcs after bathing in the Dead-sea salts’ solution, J Dermatol Treat 1993;4:195-198.
4. Shani J, Sharon R, Koren R, Even-Paz Z: Effect of Dead-sea brine and its main salts on cell growth in culture, Pharmacology 1987:35:339-347.
5. Voorhecs JJ, Duell EA: Imbalanced cAMP-cGMP in psoriasis, Adv Cyclic Nucleotide Res 1975:5:735-758.
6. Hsia SL, Wright R, Halprin KM: Adenyl cyclase in normal and psoriatic skin, J Invest Dermatol 1972; 59:109-114.
7. Walker GM: Magnesium and cell cycle, Magnesium 1986:5:9-23.
8. Ponec M, Haverkort M, Soei YL, Kempenaar J, Boddc H: Use of human keratinocyte and fibroblast cultures for toxicity studies of topically-applied compounds, J Pharmacol Sei 1990;79:312-316.
9. Marks F: The second messenger system of mouse epidermis (II) guanyl cyclase, Biochim Biophys Acta 1973;309:349-356.
10. Anonymous: Clinical observation on dibutyryl-cAMP in the treatment of psoriasis, Clin Med 1974:4:201-204.
11. Lowe NY, Breeding Y, Russel D: Cutaneous polyamines in psoriasis, Br J Dermatol 1982;107:21-26.
12. Sanui H, Rubin H: Correlated effects of external magnesium on cation content and DNA synthesis in cultured chicken fibroblasts, J Cell Physiol 1977;92:23-32.
13. Mumo GF, Miller RA, Bell CA, Verderber EL: Effect of external os-molarity on polyamine metabolism in lleLa cells, Biochim Biophys Acta 1975:411:267-281.
14. Shani J, Barak S, Ram M, Levi D, Pfeiffer Y, Schlesinger T, Avrach WW, Robberccht H, van Grieken R: Serum bromine levels in psoriasis, Pharmacology 1982;25:297-307.